Investor Files Lawsuit Against Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)
An investor, who purchased shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Aegerion Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between March 15, 2012 and January 9, 2014.
View full press release